Rakesh Jhunjhunwala and Associates's portfolio and holdings

Visit FAQs


Rakesh Jhunjhunwala (born 5 July 1960) is an Indian Investor and trader and manages the asset firm Rare Enterprises. A qualified Chartered Accountant, he invests in both his own name and his wife's, Rekha Jhunjhunwala. Jhunjhunwala has been described as India's Warren Buffett, and his investments are closely tracked by the media. He tends to favor stocks in the finance, tech, retail and pharma sectors.

As per the latest corporate shareholdings filed, Rakesh Jhunjhunwala and Associates publicly holds 26 stocks with a net worth of over Rs. 65,118.2 Cr.

These are shares held by Rakesh Jhunjhunwala and Associates as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Get a Portfolio in one click
Trendlyne RA Baskets
ADD ALL SUPERSTAR ALERTS
Expand Stock Holding Value Qty Held Dec 2025 Change % Dec 2025 Holding % Sep 2025 % Jun 2025 % Mar 2025 % Dec 2024 % Sep 2024 % Jun 2024 % Mar 2024 % Dec 2023 % History DetailsRow
Aptech 220.0 Cr 24,019,236 Filing Awaited - 41.4% 41.4% 41.4% 41.4% 41.4% 43.7% 43.7% 43.7%
Sundrop Brands 129.4 Cr 1,861,759 Filing Awaited - 4.9% 4.9% 4.9% 7.0% 7.0% 7.3% 7.5% 8.1%
Canara Bank 2,140.2 Cr 139,918,000 -0.0 1.5% 1.6% 1.5% 1.5% 1.4% 1.4% 1.5% 1.5% 2.1%
Crisil 1,795.2 Cr 3,799,000 Filing Awaited - 5.2% 5.2% 5.2% 5.2% 5.2% 5.4% 5.4% 5.5%
Valor Estate 295.9 Cr 25,000,000 Filing Awaited - 4.6% 4.6% 4.7% 4.7% 4.7% 4.7% 4.7% 3.0%
Escorts Kubota 664.6 Cr 1,708,388 Filing Awaited - 1.5% 1.5% 1.5% 1.5% 1.5% 1.6% 1.6% 1.6%
Federal Bank 1,526.2 Cr 59,030,060 Filing Awaited - 2.4% 1.5% 1.5% 1.4% 1.4% 2.5% 2.6% 3.0%
Fortis Healthcare 2,892.1 Cr 30,739,000 Filing Awaited - 4.1% 4.1% 4.1% 4.1% 4.1% 4.2% 4.1% 4.7%
Geojit Fin Serv 151.1 Cr 20,099,400 Filing Awaited - 7.2% 7.2% 7.2% 7.2% 7.0% 7.2% 7.3% 8.2%
Indian Hotels Company 2,061.0 Cr 28,810,965 Filing Awaited - 2.0% 2.0% 2.0% 2.0% 2.0% 2.1% 2.1% 2.1%
Jubilant Pharmova 1,104.3 Cr 10,244,000 Filing Awaited - 6.4% 6.4% 6.4% 6.4% 6.4% 6.6% 6.6% 6.7%
Karur Vysya Bank 1,085.4 Cr 40,185,019 Filing Awaited - 4.2% 4.2% 4.2% 4.2% 4.2% 4.3% 4.3% 4.6%
NCC 1,235.0 Cr 78,333,266 Filing Awaited - 12.5% 12.5% 12.5% 12.5% 12.5% 12.5% 12.5% 13.1%
Sun Pharma Advanced - - Filing Awaited - - - - - 1.9% 1.9% 1.9% 1.9%
Tata Communications 810.1 Cr 4,500,687 Filing Awaited - 1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.8%
Tata Motors PV 1,808.4 Cr 49,770,260 Filing Awaited - 1.4% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.6%
Titan Company 20,209.4 Cr 47,293,470 Filing Awaited - 5.3% 5.2% 5.2% 5.1% 5.1% 5.3% 5.4% 5.4%
Va Tech Wabag 615.5 Cr 5,000,000 Filing Awaited - 8.0% 8.0% 8.0% 8.0% 8.0% 8.0% 8.0% 8.0%
Wockhardt 429.0 Cr 2,837,005 Filing Awaited - 1.8% 1.8% 1.8% 1.8% 1.9% 1.9% 1.9% 2.0%
Singer 28.4 Cr 4,250,000 Filing Awaited - 6.9% 6.9% 6.9% 6.9% 7.0% 7.0% 7.0% 7.0%
Raghav Productivity Enhancers 206.4 Cr 2,205,704 0.0 4.8% 4.8% 4.8% 4.8% 4.8% 4.8% 5.0% 5.1% 5.1%
Nazara Technologies - - Filing Awaited - - - 7.1% 7.2% 8.1% 8.4% 8.5% 9.0%
Jubilant Ingrevia 345.4 Cr 4,735,500 Filing Awaited - 3.0% 3.0% 3.0% 3.0% 3.0% 3.1% 3.1% 3.1%
Star Health 4,479.0 Cr 100,753,935 Filing Awaited - 17.1% 17.1% 17.1% 17.1% 17.2% 17.2% 17.2% 17.2%
Metro Brands 3,017.7 Cr 26,102,394 Filing Awaited - 9.6% 9.6% 9.6% 9.6% 9.6% 9.6% 9.6% 9.6%
Concord Biotech 3,452.5 Cr 25,199,240 Filing Awaited - 24.1% 24.1% 24.1% 24.1% 24.1% 24.1% 24.1% 24.1%
Baazar Style Retail 65.7 Cr 2,532,500 Filing Awaited - 3.4% 3.4% 3.4% 3.7% 3.7% - - -
Inventurus Knowledge 14,350.4 Cr 84,668,326 Filing Awaited - 49.3% 49.3% 49.3% 49.3% - - - -